Company intelligence
Amnio
Amnio is an AI company developing technologies that change not just how fetal anomalies are found - but when.
About Amnio
Amnio utilizes 3D ultrasound and AI to deliver a detailed fetal anatomy assessment and measurements in the first trimester. Earlier Answers, Better Outcomes.
Verified activity
Signals from Amnio
11 published signals
Presence & Recognition
Amnio attended the ISUOG 2026 stand and spoke with attendees about fetal assessment and early clinical workflows.
Reported by Amnio
Research & Knowledge
Amnio is trained by Dr Maoz Gelbart on 3D datasets.
Reported by Amnio
Presence & Recognition
Amnio participated in day 2 of ISUOG2026 with a discussion between Shahrzad Khojasteh and Daniel Ushakov.
Reported by Amnio
Presence & Recognition
Amnio attended the Trice booth at the ISUOG2026 conference.
Reported by Fred Ushakov
Products & Services
Amnio tested its AI fetal ultrasound measurement on Canon Medical Systems Europe's first-trimester 3D ultrasound volumes.
Reported by Amnio
Presence & Recognition
Amnio received a positive response from delegates at the Day one of ISUOG2026 event.
Reported by Amnio
Presence & Recognition
Amnio is attending booth 16 at the Trice team event tomorrow at 10:40am.
Reported by Fred Ushakov
Presence & Recognition
Amnio hosted the Chief Medical Director Dr Fred Ushakov at booth 16 during the ISUOG2026 event on Saturday 5/9.
Reported by Amnio
Presence & Recognition
Amnio is attending the ISUOG International Society of Ultrasound in Obstetrics and Gynecology 2026 event.
Reported by Amnio
Products & Services
Amnio allows clinicians worldwide to perform earlier and more detailed anomaly scans
Reported by Fred Ushakov
Products & Services
Amnio is launching a new project at the 36th ISUOG World Congress in London, combining 3D ultrasound, automated fetal structure recognition, and AI to support the 10 Week Scan.
Reported by Fred Ushakov